| Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms JA Mikszta, VJ Sullivan, C Dean, AM Waterston, JB Alarcon, JP Dekker III, ... Journal of Infectious Diseases 191 (2), 278-288, 2005 | 200 | 2005 |
| Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release BG Stiles, S Bavari, T Krakauer, RG Ulrich Infection and immunity 61 (12), 5333-5338, 1993 | 175 | 1993 |
| Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine JA Mikszta, JP Dekker III, NG Harvey, CH Dean, JM Brittingham, J Huang, ... Infection and immunity 74 (12), 6806-6810, 2006 | 144 | 2006 |
| Development of engineered vaccines effective against structurally related bacterial superantigens RG Ulrich, MA Olson, S Bavari Vaccine 16 (19), 1857-1864, 1998 | 119 | 1998 |
| Anthrax vaccine powder formulations for nasal mucosal delivery GE Jiang, SB Joshi, LJ Peek, DT Brandau, J Huang, MS Ferriter, ... Journal of pharmaceutical sciences 95 (1), 80-96, 2006 | 110 | 2006 |
| Evaluation of the effect of syringe surfaces on protein formulations S Majumdar, BM Ford, KD Mar, VJ Sullivan, RG Ulrich, AJM D'souza Journal of pharmaceutical sciences 100 (7), 2563-2573, 2011 | 104 | 2011 |
| Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model BG Stiles, AR Garza, RG Ulrich, JW Boles Infection and immunity 69 (4), 2031-2036, 2001 | 101 | 2001 |
| Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells KU Saikh, TL Kissner, A Sultana, G Ruthel, RG Ulrich The Journal of Immunology 173 (12), 7426-7434, 2004 | 94 | 2004 |
| Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A S Bavari, B Dyas, RG Ulrich Journal of Infectious Diseases 174 (2), 338-345, 1996 | 94 | 1996 |
| Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity JW Boles, MLM Pitt, RD LeClaire, PH Gibbs, E Torres, B Dyas, RG Ulrich, ... Clinical Immunology 108 (1), 51-59, 2003 | 90 | 2003 |
| Staphylococcal enterotoxin B and related pyrogenic toxins RG Ulrich, S Sidell, TJ Taylor, CL Wilhelmsen, DR Franz Medical aspects of chemical and biological warfare, 621-630, 1997 | 90 | 1997 |
| Protection against Staphylococcus auveus Sepsis by Vaccination with Recombinant Staphylococcal Enterotoxin A Devoid of Superantigenicity IM Nilsson, M Verdrengh, RG Ulrich, S Bavari, A Tarkowski The Journal of infectious diseases 180 (4), 1370-1373, 1999 | 87 | 1999 |
| Laboratory exposures to staphylococcal enterotoxin B JM Rusnak, M Kortepeter, R Ulrich, M Poli, E Boudreau Emerging infectious diseases 10 (9), 1544, 2004 | 85 | 2004 |
| Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules RG Ulrich, S Bavari, MA Olson Nature structural biology 2 (7), 554-560, 1995 | 85 | 1995 |
| Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines L DaSilva, BC Welcher, RG Ulrich, MJ Aman, CS David, S Bavari The Journal of infectious diseases 185 (12), 1754-1760, 2002 | 82 | 2002 |
| Bacterial superantigens in human disease: structure, function and diversity RG Ulrich, S Bavari, MA Olson Trends in microbiology 3 (12), 463-468, 1995 | 76 | 1995 |
| Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B EA Larkin, BG Stiles, RG Ulrich PloS one 5 (10), e13253, 2010 | 71 | 2010 |
| IL-15-induced conversion of monocytes to mature dendritic cells KU Saikh, AS Khan, T Kissner, RG Ulrich Clinical & Experimental Immunology 126 (3), 447-455, 2001 | 71 | 2001 |
| Cross-Reactive Antibodies Prevent the Lethal Effects of Staphylococcus auveus Superantigens S Bavari, RG Ulrich, RD LeClaire The Journal of infectious diseases 180 (4), 1365-1369, 1999 | 71 | 1999 |
| Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis JN Tournier, RG Ulrich, A Quesnel-Hellmann, M Mohamadzadeh, ... Expert review of anti-infective therapy 7 (2), 219-236, 2009 | 70 | 2009 |
